A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants | MicrobiomeTrials← Back to trialsNCT06663332
A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
RecruitingPHASE3INTERVENTIONAL
Trial Details
Start: 2024-10-29Est. Completion: 2031-12-12
Enrollment target: 196 participants Locations- Emory University, Atlanta, Georgia, United States
- Children's Center for Digestive Healthcare, Atlanta, Georgia, United States
- Riley Hospital for Children, Indianapolis, Indiana, United States
- Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States
- University of Utah, Salt Lake City, Utah, United States
- Instituto Caici, Rosario, Argentina
- The Kids Research Institute Australia on behalf of the Centre for Child Health Research, Nedlands, Australia
- Mater Hospital Brisbane Inflammatory Bowel Diseases, South Brisbane, Australia
- The Children's Hospital at Westmead, Westmead, Australia
- Hospital das Clinicas - UFG, Goiânia, Brazil
- INTEGRAL Pesquisa e Ensino, Votuporanga, Brazil
- Capital Center For Children's health Capital Medical University, Beijing, China
- Changzhou No 2 Peoples Hospital, Changzhou, China
- The Childrens Hospital Zhejiang University School Of Medicine, Hangzhou, China
- Sir Run Run Shaw Hospital Zhejiang University School of Medicine, Hangzhou, China
- Ruijin Hospital Shanghai Jiao Tong University, Shanghai, China
Other microbiome trials you might be interested in
Inflammatory Bowel DiseaseCrohn's DiseaseUlcerative Colitis
Background:
Inflammatory bowel disease (IBD) is a term used to describe disorders that cause long-term inflammation in …
Bethesda, United StatesEst. completion Jun 1, 2036
Inflammatory Bowel Disease (IBD)
This observational study will use intestinal ultrasound images to help develop computer programs that may make it easier…
Vancouver, CanadaEst. completion Feb 1, 2027
Shengjing Hospital Of China Medical University, Shenyang, ChinaHospital Center University De Lille, Lille, FranceSchon Klinik Hamburg Eilbek, Hamburg, GermanyAsklepios Klinik Sankt Augustin, Sankt Augustin, GermanyASST Papa Giovanni XXIII Bergamo, Bergamo, ItalyAzienda USL di Bologna - Ospedale Maggiore, Bologna, ItalyIRCCS Ospedale Pediatrico Bambino Gesu, Roma, ItalyCasa Sollievo Della Sofferenza IRCCS, San Giovanni Rotondo, ItalyIRCCS Materno Infantile Burlo Garofolo, Trieste, ItalyTokyo Metropolitan Children's Medical Center, Fuchū, JapanKanazawa University Hospital, Kanazawa, JapanKobe University Hospital, Kobe, JapanJapanese Red Cross Kumamoto Hospital, Kumamoto, JapanShinshu University Hospital, Matsumoto, JapanSaga University Hospital, Saga, JapanYokohama City University Medical Center, Yokohama, JapanAkershus Universitetssykehus, Akershus, NorwayKorczowski Bartosz Gabinet Lekarski, Rzeszów, PolandCentrum Zdrowia Dziecka i Rodziny im Jana Pawla II w Sosnowcu Sp z o o, Sosnowiec, PolandMedical Network, Warsaw, PolandInstytut Pomnik Centrum Zdrowia Dziecka, Warsaw, PolandUls Braga - Hosp. Braga, Braga, PortugalUls Sao Joao - Hosp. Sao Joao, Porto, PortugalSeverance Hospital Yonsei University Health System, Seoul, South KoreaSamsung Medical Center, Seoul, South KoreaHosp. Clinico Univ. de Santiago, Santiago de Compostela, SpainHosp. Univ. I Politecni La Fe, Valencia, SpainGazi University Medical Faculty, Ankara, Turkey (Türkiye)Umraniye Training and Research Hospital, Istanbul, Turkey (Türkiye)Kocaeli Universitesi Hastanesi, Kocaeli, Turkey (Türkiye)Sheffield Children's Hospital, Sheffield, United KingdomRoyal Stoke University Hospital, Stoke-on-Trent, United KingdomHaywood Hospital, Stoke-on-Trent, United KingdomPhase 4
Recruiting
Children Aged 6 Years and Above With Moderate - to - Severe Active Crohn's Disease
This study is a real - world clinical research of adalimumab. The project plans to enroll 30 subjects, aiming to evaluat…
Guangzhou, ChinaEst. completion Mar 2029